Shopping Cart
- Remove All
- Your shopping cart is currently empty
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) acts as a substrate-specific peptide inhibitor of MLCK and inhibits hypotonicity-induced Ca2+ entry, with applications in human cervical cancer research [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) acts as a substrate-specific peptide inhibitor of MLCK and inhibits hypotonicity-induced Ca2+ entry, with applications in human cervical cancer research [1] [2]. |
In vitro | Myosin light chain kinase fragment 11-19 amide (5 μM) reduces the amplitude and slows the activation kinetics of noradrenaline-induced non-selective cation current (I_cat) in rabbit portal vein myocytes [1]. |
Alias | MLCK(11-19) amide |
Molecular Weight | 987.16 |
Formula | C40H78N18O11 |
Cas No. | 119386-39-9 |
Storage | keep away from moisture | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.